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Objective: Past publications have highlighted an excess rheumatic disease incidence and prevalence in
indigenous populations of Canada (First Nations, Inuit, and Métis), and the United States of America
(Alaska Native and American Indian). We have updated these reviews and expanded the scope to include
New Zealand (Maori) and Australia (Aborigine) indigenous populations.
Methods: We performed a broad search using medical literature databases, indigenous speciﬁc online
indexes, and government websites to identify publications reporting the incidence and/or prevalence of
arthritis conditions (rheumatoid arthritis, spondyloarthropathies, gout, osteoarthritis, systemic auto-
immune rheumatic diseases, and juvenile idiopathic arthritis) in the indigenous populations of Canada,
America, New Zealand, and Australia. A narrative synthesis by type of arthritis was prepared given the
heterogeneity of study designs used in the primary studies.
Results: Of 5269 titles and abstracts, 88 met inclusion criteria. Osteoarthritis was found to affect up to
17% of American Indian/Alaska Native women, 22% of Canadian First Nations, 32% of Australian Aborigine,
and 6% of New Zealand Maori populations. The prevalence of rheumatoid arthritis, systemic lupus
erythematosus, and juvenile idiopathic arthritis was consistently signiﬁcantly higher in indigenous
populations. Several studies describing the prevalence of spondyloarthropathy in North American
northern populations were identiﬁed, but with no comparison populations the relative frequency could
not be commented on. Gout was more prevalent in Maori compared to general population New
Zealanders.
Conclusions: This comprehensive summary describes rheumatic disease burden in indigenous popula-
tions in four countries with similar disparities in social determinants of health, to inform clinical service
requirements to meet population need.
& 2016 The Authors. Published by Elsevier HS Journals, Inc. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Past reviews describing the epidemiology of rheumatic diseases in
indigenous populations of North America have highlighted higher
prevalence rates of rheumatoid arthritis [1,2], lupus, connective tissue
diseases, and spondyloarthropathies than in the general population
[1]. Associations between patterns of migration and ancestry to
disease prevalence and severity were thought to be suggestive of a
genetic etiology of rheumatic disease [1,2]. An emerging theme
around disparities in determinants of health and resulting health
impacts for indigenous populations [3] also informs the understandingr HS Journals, Inc. This is an open
e research was funded by the
g School of Medicine) and
ndation Scheme Grant (FDN
).of distribution of disease. For example, environmental exposures such
as smoking and air pollution are associated with an increased risk of
rheumatoid arthritis and systemic autoimmune rheumatic diseases in
indigenous populations of Canada respectively [4,5]. In an example
from the diabetes literature, cultural continuity has been associated
with disease prevalence in Canadian First Nations populations [6].
indigenous populations of Canada (until 2016), the United States of
America, Australia, and New Zealand exist in similar socio-political
contexts; these are the only countries that rejected the United Nations
Declaration on the Rights of indigenous Peoples [7], and share
similarities in difﬁculties in access to healthcare coverage [8]. Expand-
ing the prior reviews to include data from Australia and New Zealand
would equally inform our understanding of disease patterns in
marginalized populations, so that appropriate and relevant health
systems reforms can be developed.
To that end, we have undertaken a large systematic review to
describe the epidemiology and outcomes of rheumatic diseases in
indigenous populations from Canada (First Nations, Inuit, andaccess article under the CC BY-NC-ND license
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Indian), New Zealand (Maori), and Australia (Aborigine). A third
objective of our work was to describe health services use by
indigenous populations with arthritis conditions in these coun-
tries. In this ﬁrst part of the review, we present all identiﬁed
articles describing the incidence and prevalence of rheumatic
diseases in indigenous populations from the four countries of
interest.Methods
Data sources
We performed a broad search using medical literature data-
bases and indigenous speciﬁc online indexes and organization
websites identiﬁed with the help of a medical librarian. Medical
literature databases searched included Medline (1946 to June
2015), EMBASE (1980 to June 2015) and CINAHL (1996 to June
2015). indigenous speciﬁc online indexes and organization web-
sites searched (June 2015) were the Circumpolar Health Database,
Health Info Net, Metis Health Database, Native Health Database,
Native indigenous Studies Portal, and The First Nations Periodical
Index. We also searched each country’s government websites for
relevant publications. References of relevant identiﬁed studies
were reviewed for additional primary references.
Search terms
Keywords and Medical Subject Headings (MESH) for the terms
“arthritis and “indigenous populations” were selected with the
assistance of a medical librarian. An example of the search strategy
(conducted in Medline) is provided in Appendix A. We used an
expanded version of a “3E” search strategy developed for identify-
ing studies on inﬂammatory arthritis [9], and including search
terms that have been used to identify arthritis conditions such as
osteoarthritis [10], gout [11], juvenile idiopathic arthritis, systemic
lupus erythematosus [12], scleroderma, polymyositis, dermato-
myositis, Sjögren’s syndrome, as well as terms for general arthritis
and rheumatic disease. Search terms for indigenous populations of
interest used both global and local terminology. Only the arthritis
search terms were used during the indigenous online indexes and
websites review. No language or publication date restrictions were
imposed during the electronic search. The literature search was
not limited by outcomes terms.
Inclusion criteria
In this part of the study, we identiﬁed studies specifying
estimates of prevalence and/or incidence of arthritis conditions
in indigenous populations [13] from Australia, Canada, New
Zealand, and the USA.
Data collection and analysis
Two review authors (C.B. and K.E.) independently screened
titles and abstracts and performed the full-text review. Disagree-
ments were resolved by consensus. Review articles and articles
with secondary data were included during the initial eligibility
screening and when available, the primary studies were obtained
and used for data extraction. The authors then extracted the data
from included studies using standardized and pre-tested data
extraction forms to collect information on the country of study,
the indigenous population and size described, details on the
comparison population and size if relevant, study design, type of
arthritis and method of case determination, and the speciﬁedoutcomes of disease incidence and prevalence. Adjusted or stand-
ardized estimates including covariates and reference population
were also extracted.
Data synthesis
Data were grouped for presentation by type of arthritis. A
narrative synthesis was prepared given the heterogeneity of
populations, study methods, and outcomes reported.Results
Study characteristics
This study was part of a larger initiative to synthesize epidemi-
ology, clinical outcomes, and health services use in indigenous
populations in the four countries of interest. A total of 5269 titles
and abstracts were reviewed, of which 504 underwent full-text
review for any of the three outcomes above, and 88 were included
as they reported epidemiology estimates in indigenous popula-
tions (Fig. 1).
Arthritis and rheumatism
A total of 20 articles collected information on the prevalence of
self-reported diagnoses of arthritis and/or rheumatism. In Alaska
Natives, the prevalence of healthcare professional diagnosed
arthritis conditions ranged from 19% in the Behavioral Risk Factor
Surveillance System survey in 2001, up to 26% in the Education and
Research Towards Health survey (2004–2007) [14,15]. In three
studies, prevalence in American Indian and Alaska Native popula-
tions were combined; with estimates of self-reported arthritis of
18% in the National Health Interview Survey [16] and 20% in the
1987 National Medical Expenditure Survey which included adults
419 years of age [17], and self-reported arthritis or rheumatism in
43% of adults 445 years of age [18]. In American Indian popula-
tion studies [14,19-24] the prevalence of healthcare professional
diagnosed arthritis ranged from 17% in the Southwest US [14] up to
56% of self-reported arthritis in the Chippewa population [19].
Several estimates for Canadian Aboriginal populations are avail-
able from national studies [25–29]. In the most detailed publica-
tion, First Nations prevalence of healthcare professional diagnosed
arthritis was reported to vary from 14% for northern populations
up to 20% in southern populations; in Métis and those identifying
to be of multiple Aboriginal groups prevalence was 13% in north-
ern populations and 21% in southern populations, and in the Inuit
prevalence was 2–14% [30]. In an on-reserve survey of three First
Nations communities in British Columbia, the prevalence of
healthcare professional diagnosed arthritis was 30% [31], and in
an urban city of Ontario, prevalence in First Nations participants
was 31% [32]. A single study from Australia estimated the preva-
lence of healthcare professional diagnosed arthritis at 14% in the
indigenous population, signiﬁcantly higher than 11% in the non-
indigenous population, for adults ages 18–64 [33] (Table 1).
Osteoarthritis
Estimates using Indian Health Services data provide data on the
prevalence of osteoarthritis being 2.4% in the Mohawk population
[34], and 11.5% in males and 16.5% in females of American Indian
and Alaska Native populations residing in California [35]. In
Canada, First Nations prevalence estimates vary from 6% in
Manitoba (compared to 3.4% in the non-First Nations population)
[26] to 16% in Alberta (compared to 7.8% in the non-First Nations
population) [36] using administrative databases, and up to 22% in
Fig. 1. Article selection.
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mated to affect 1.5% of the Inuit population [38]. In Australia
populations, the prevalence of osteoarthritis at multiple joints
(metatarsophalangeal joints, acromioclavicular joints, and hands)
was 7–32%, and at the knee alone 5–14%, in Aurukun and Weipa
populations, respectively [39]. More recent data using the COP-
CORD case ﬁnding methodology found a prevalence of 18% in the
Yarrabah population [40], compared to just 6.4% estimated in a
national self-reported diagnosis study [33]. The only publications
from New Zealand were from over 50 years ago, with an osteo-
arthritis prevalence of 4.3% in the Whanau-a-apannui population
[41] and 6.1% in the Ruatahuna population [42] (Table 2).Rheumatoid arthritis
The majority of the epidemiologic data for rheumatoid arthritis
has come from North American indigenous populations (Fig. 2). In
northern and western Alaska Native populations, estimates
reported ranged between 0.5% and up to 1.8% after age adjustment
in the Inupiat [43–47]. However, in the southeast populations of
Tlingt, Haida, and Tsimshian tribes, rheumatoid arthritis preva-
lence after age adjustment was relatively increased at 2.4%, with
incidence rates of 46/100,000 per year in males and 122/100,000
per year in females [48]. In one study the incidence rate of
“rheumatoid disease” (including all of rheumatoid arthritis, spon-
dyloarthritis, and juvenile rheumatoid arthritis) for the Alaska
Indian Health Service area was 23 per 100,000 per year [49], but in
a separate study looking at rheumatoid arthritis incidence alone,
estimates were 26.4 and 56.7 per 100,000 per year in males and
females from the Yupik (western) population, respectively [43].
Studies from American Indian populations were also retrieved. A
longitudinal study in the Pima Indian population has generated
several publications and estimates comparing a variety of criteria
for rheumatoid arthritis [50–57]. In the summative publication,
prevalence of rheumatoid arthritis comparing three time cohorts
(1966–1973, 1974–1982, and 1983–1990) over 25 years was reported
[50]. After age adjustment, rheumatoid arthritis prevalencedecreased from 5.2% in females in the earliest time cohort down to
3.1% in the last time cohort, with prevalence estimates in males also
decreasing from 1.4% to 1.0% over that time. Prevalence has been
estimated at approximately 4% after age and sex adjustment in the
Blackfeet population [52,58]. Rheumatoid arthritis prevalence was
6.8% in the Chippewa population [59], and 3.4% in Yakima females
[60]. Incidence rates in the American Indian population using Indian
Health Service data for “rheumatoid disease” ranged from 3 to 27 per
100,000 per year [49]. Age- and sex-adjusted incidence rates of
rheumatoid arthritis in the Pima population decreased from 8.9 per
1000 person-years in 1966–1973 to 3.8 per 1000 person-years in
1983–1190 [50] with sex stratiﬁed rates from 1965–1984 also
reported in one publication [55].
A single study of a Canadian Inuit population reported an age-
adjusted prevalence of rheumatoid arthritis at 0.65%, with an
incidence of 48.2 per 100,000 per year [38]. Data from admin-
istrative databases or medical records of various Canadian First
Nations groups have been published. In British Columbia popula-
tions, the estimated prevalence in the Nuh-Chah-Nulth was 1%
[61], 1.5% in females and 0.4% in males of Haida heritage [62], 1.3%
in the Bella Bella population [63], and ranging from 3.4% to –17%
by self-report in three communities served by the Kwakiutl
District Council [37]. In Alberta First Nations people, rheumatoid
arthritis prevalence was 1.9% compared to 1.1% in the non-First
Nations population [64]. In Manitoba, age-adjusted rheumatoid
arthritis prevalence was estimated at 1.0%, compared to 0.4% in the
non-First Nations population [26,65].
Rheumatoid arthritis prevalence has not been detailed exten-
sively in Australian populations (Fig. 3). In one article describing
arthritis syndromes in a community, a single case of rheumatoid
arthritis was found, but with no denominator reported [39]. In
non-remote populations, rheumatoid arthritis affected 2.7% (95%
CI: 1.7–3.7) of Australian indigenous people, compared to 1.9%
(95% CI: 1.6–2.1) of non-indigenous people [33]. Two older studies
of New Zealand Maori reported rheumatoid arthritis prevalence to
be 3.3% in Tuhoe Maori [42], 1.1% in the Rotorua Maori compared to
6.7% in non-Maori, and with no cases of RA found in the Whanau-
A-Apanui population [41].
Table 1
Self-reported arthritis and/or rheumatism prevalence in the indigenous populations of the United States of America, Canada, Australia, and New Zealand
Author Years of study Source of data Criteria Indigenous population
Indigenous
prevalence estimate
Comparison
population
Comparison
population
prevalence
estimate
Wells [15] 2003 Behavioral risk factor surveillance system
(national survey)
Self-report of arthritis conditions
(arthritis, RA, gout, lupus, and FM)
diagnosis by HCP
Alaska Native 418 years 19% Non-Native 17% (non-
signiﬁcant
difference)
Ferucci et al. [14] 2004–2007 Education and research toward health (regional
survey)
Self-report of arthritis diagnosis by
healthcare professional
Alaska Native 418 years 26% (age–sex
adjusted to 2000
US population)
None
National Indian Council
on Aging [18]
1980 National survey Self-report of arthritis and rheumatism Alaska Native and American
Indian 445 years
43% None
Johnson and Taylor [17] 1987 Survey of American Indians and Alaska Natives
and National Medical Expenditure Survey II
Household Survey
Self-report of arthritis diagnosis by
healthcare professional
Alaska Native and American
Indian 419 years
20% (age-adjusted to
US population)
General
population
20% (non-
signiﬁcant
difference)
Lawrence et al. [16] 1989–1991 National Health Interview Survey Self-report of arthritis American Indian, Eskimo,
Aleut
18% (age adjusted) White 15% (non-
signiﬁcant
difference)
John et al. [20] Not speciﬁed
(published
2003)
On-reserve survey Self-report of arthritis or rheumatism
diagnosis by healthcare professional
American Indian 460
years
50% None
Balluz et al. [21] 2001–2004 Behavioral Risk Factor Surveillance System
(national survey)
Self-report of arthritis diagnosis by
healthcare professional
American Indian 450
years
53% (age-adjusted to
2000 US
population)
Non-
Hispanic
White
46% (signiﬁcant
difference)
Hodge et al. [22] 1991 Regional survey Self-report of arthritis and rheumatism American Indian 418 years
(California reserves and
urban)
24% None
Hodge et al. [23] 2002–2003 Regional survey Self-report of arthritis American Indian 418 years
(California reserves)
25% None
Elliott et al. [19] Not speciﬁed
(published
2000)
On-reserve survey Self-report of arthritis American Indian 418 years
(Chippewa)
56% None
Joos and Ewart [24] 1985 Tribal survey Self-report of arthritis and rheumatism American Indian 445
years (Klamath)
39% None
Ferucci et al. [14] 2004–2007 Education and Research Towards Health
(regional survey)
Self-report of arthritis diagnosis by
healthcare professional
American Indian 418 years
(Southwest US)
17% (age–sex
adjusted to 2000
US population)
None
Chan et al. [28] 2009–2010 Canadian Community Health Survey Self-report of arthritis Canadian Aboriginal (First
Nations, Inuit, Métis)
18% Non-
Aboriginal
15% (signiﬁcant
difference)
Barnabe et al. [26] 1997–2002 Manitoba First Nations Regional Longitudinal
Health Survey
Self-report of arthritis Canadian First Nations
(Manitoba)
21% None
Public Health Agency
of Canada [25]
2002–2003 First Nations Regional Longitudinal Survey Self-report of arthritis and rheumatism Canadian First Nations
420 years
19% None
Ng et al. [30] 2006 Aboriginal Peoples Survey Self-report of arthritis and rheumatism
diagnosis by healthcare professional
Canadian First Nations 14% north, 20% south None
Public Health Agency
of Canada [25]
2006 Canadian Community Health Survey Self-report of arthritis Canadian First Nations 415
years
18% General
population
15% (signiﬁcant
difference)
Firestone et al. [32] 2009–2010 Urban survey Self-report of arthritis diagnosis by
healthcare professional
Canadian First Nations 418
years
31% None
Lehman et al. [31] not speciﬁed
(published
2011)
On-reserve survey Self-report of arthritis diagnosis by
healthcare professional
Canadian First Nations
(Kwakiutl District
Council)
30% None
Statistics Canada [27] 2006 Aboriginal Peoples Survey Self-report of arthritis and rheumatism
diagnosis by healthcare professional
Canadian Inuit 415 years 10% None
2006 Aboriginal Peoples Survey Self-report of arthritis and rheumatism Canadian Inuit 415 years 13% (12% north, 14%
south)
None
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Studies characterizing spondyloarthropathies as a group, and
with speciﬁcation for the type of spondyloarthritis as ankylosing
spondylitis, psoriatic arthritis, and reactive arthritis were
retrieved. As detailed in two publications using Alaska Area Native
Health Service patient registry data, the prevalence of spondy-
loarthropathy in people 420 years of age was 2.7% in the northern
Alaska Inupiat population, and 2.4% in the southwestern Yupik
population [66,67]. This was increased compared to a prevalence
estimate of 0.5% in the Yupik population in an earlier study [43]. In
the southeast Tlingit, Haida, and Tsimshian populations, preva-
lence was reported to be 1.1% [48]. In a community survey of First
Nations from the Kwakiutl District Council, rates of spondyloarthr-
opathy varied between 0.5% and 8.0% depending on the criteria
used to classify cases [37]. In Canadian Inuit, both point and period
prevalence of spondyloarthopathy were estimated at 840 cases per
100,000, and incidence was 60 cases per 100,000 population per
year, after age and sex adjustment to a comparison population
[38]. None of these studies included a comparison population.
The prevalence of ankylosing spondylitis in the Alaska Native
Inupiat and Yupik populations ranged from 0.1% to 0.5% in several
studies based on data from the Alaska Area Native Health Service
database and computerized patient records [43,47,66,67]. One case
ﬁnding study of on-reserve Blackfeet and Pima Indians reported
age and sex adjusted prevalence of 0.0% and 3.0%, respectively
[52]. In a separate study of Pima Indian males aged 415 years
using New York criteria for case deﬁnition, the prevalence of
ankylosing spondylitis was 4.5%, compared to 4.7% in Haida males,
2.1% in Bella Coola males, and 6.3% in Bella Bella males (aged 420
years) [68]. An older case ﬁnding study performed in a Canadian
Haida First Nations community found ankylosing spondylitis to
affect 4.2% of males, and 2.3% of the entire population [69]. In
contrast, a more recent study of Alberta First Nations using
administrative data sources reported an ankylosing spondylitis
prevalence of only 0.36%, signiﬁcantly higher than the prevalence
in non-First Nations at 0.21% [64]. In a case ﬁnding survey in the
Kwakiutl District Council of British Columbia, ankylosing spondy-
litis prevalence was estimated at 0.9% [37]. In the Canadian Inuit
population, period and point prevalence estimates of ankylosing
spondylitis were 194 per 100,000 population and the incidence
was 5.1 cases per 100,000 per year, with both estimates adjusted
for age and sex to the Manitoba population [38]. Only one case
ﬁnding study examined the prevalence of ankylosing spondylitis in
the New Zealand Maori of Ruatahuna, and reported a rate of 0.0%
[42].
Psoriatic arthritis was not widely studied. Reported prevalence
estimates in the Alaska Native Inupiat and Yupik populations were
all o0.1% [43,47,66,67]. Similarly, the only Canadian study on
psoriatic arthritis prevalence in First Nations in Alberta reported a
rate of 0.07%, lower than the Caucasian prevalence at 0.09% [64].
One article from Australia reported that the point prevalence of
psoriatic arthritis in Australian Aborigines from Yarrabah was 0.5%
(95% CI: 0.0–0.9) [40].
The prevalence of reactive arthritis in Alaskan Inupiat and
Yupik populations ranged from 0.2% to 1.3% [43,47,66,67]. Cana-
dian First Nations in Alberta were reported to have a prevalence of
reactive arthritis of 0.1% compared to 0.04% in non-First Nations
[64]. In the Canadian Inuit population, the period prevalence of
reactive arthritis was 380 per 100,000 and the point prevalence
was 120 per 100,000 after age and sex adjustment, with an
incidence rate of 25 per 100,000 per year [38]. A single article
on reactive arthritis prevalence in Australian Aborigines from
Yarrabah estimated using COPCORD methodology reported a point
prevalence of 0.1% (95% CI: 0.1–0.3) in this population [40].
Fig. 2. Prevalence of rheumatoid arthritis in indigenous populations of Canada and the United States of America. Most recent prevalence estimates published are shown.
Data for the Pima and Haida populations are the average of estimates in male and female groups. Data for the Yakima population are for the female population only.
Table 2
Osteoarthritis prevalence in the indigenous populations of the United States of America, Canada, Australia, and New Zealand
Author
Years of
study
Source of data for case determination
Country Indigenous population
Osteoarthritis prevalence
estimate
Negoita et al. [34] 1992–1997 ICD codes in administrative database USA Mohawk 2.4%
Reid et al. [35] 2002–2006 ICD codes in administrative database USA American Indian/Alaska Native
(California)
11.5% males and 16.5%
females
Oen et al. [38] 1972–1982 Clinical visit and investigations Canada Inuit 1.5% (age/sex adjusted)
Barnabe et al. [26] 1986–1996 ICD codes in administrative database Canada First Nations (Manitoba) 5.8% (age/sex adjusted)
Barnabe et al. [36] 1993–2010 ICD codes in administrative database Canada First Nations (Alberta) 16.0%
Schmidt et al. [37] 2014 Self-reported survey Canada First Nations (Kwakiutl District
Council)
22%
Douglas [39] 1965 Clinical visit and physician survey Australia Aurukun 7% (multiple joints) and 5%
(knee)
Weipa 32% (multiple joints) and 14%
(knee)
Minaur et al. [40] 2002 COPCORD Australia Yarrabah 18.0%
Cunningham [33] 2004–2005 Self-reported national survey Australia Aborigine 6.4%
Lennane et al. [41] 1956 Clinical visit and investigations New Zealand Whanau-a-apannui 4.3%
Rose and Prior [42] pre-1963 Clinical visit and investigations New Zealand Ruatahuna 6.1%
ICD, International Classiﬁcation of Diseases; COPCORD, Community Oriented Program for Control of Rheumatic Diseases.
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Fig. 3. Prevalence of rheumatoid arthritis in indigenous populations of Australia and New Zealand. Most recent prevalence estimates published are shown.
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A single article reported the prevalence of gout in the Alaska
Native Inupiat population to be 0.3% [47]. Using population-based
administrative data sources and including all crystal arthritis
conditions, the prevalence in Canadian First Nations from Alberta
was estimated at 0.44%, signiﬁcantly lower than 1.28% in the non-
First Nations population [64]. In an Australian Aborigine popula-
tion from Yarrabah, the point prevalence of gout was estimated to
be 3.8% (95% CI: 2.5–5.1) [40].
Many studies on the epidemiology of gout in New Zealand
Maori have been published. Based on community case ﬁnding
methodology, the prevalence of deﬁnite gout was 2.4% and
probable gout 3.8% in New Zealand Maori [42,70]. In an extension
of this work, deﬁnite gout affected 5.8% of New Zealand Maoris,
compared to 1.3% of Rarotongans and 2.4% of Pukapukans [71].
Using linked datasets and a capture-recapture methodology, the
prevalence of gout in males 420 years of age in Aotearoa New
Zealand Maori was estimated at 7.3% [72], three times the
prevalence of those of European descent. In other studies with
comparison populations, gout prevalence was 10.3% in Maori from
the Wairoa District and Christchurch City, compared to 2.3% in
non-Maori of the same regions [73]; and 6.4% in Maori from
Rotorua compared to 2.9% in Europeans [74]. A separate study
estimated gout prevalence in Maori at 7.9% compared to 2.9% in
the non-Maori non-Paciﬁc population [75]. In an epidemiologic
survey of gout in the Whanau-a-apannui population, prevalence
was estimated at 4.8%, and in the Maori of Rotorua at 2.7% [41]. In
an 11-year prospective study design, gout prevalence wasestimated at 8.8% for males and 0.8% for females, with incidence
at 10.3% for males and 4.3% for females [76].
Finally, prevalence of gout in selected populations of New
Zealand has also been described. In Maori males working at a
motor assembly plant, the self-reported prevalence of gout was 8%
[77]. A population of diabetic New Zealand Maori and Europeans
self-reported a diagnosis of gout of 29% (95% CI: 16–42) and 27%
(95% CI: 16–39), respectively; this difference was not statistically
signiﬁcant [78].Systemic lupus erythematosus
In the Alaska Native population in the 1970s and 1980s,
prevalence rates of systemic lupus erythematosus were calculated
at 44 per 100,000 population in the Inupiat population [47], and
112 per 100,000 population in the Tlingit, Haida, and Tsimshian
populations after adjustment for age structure [79]. In a more
contemporary study of Alaska Native populations, the age-
adjusted rate of systemic lupus erythematosus using a case
deﬁnition of Z4 American College of Rheumatology criteria was
149 per 100,000 population [80]. In this same study, the preva-
lence rates in the Oklahoma American Indian population were
estimated at 138 per 100,000 population, whereas rates were
signiﬁcantly higher in the Phoenix American Indian population at
248 per 100,000 population using the varied case deﬁnitions [80].
However, these estimates fall in line with those from a Medicaid
database for American Indians, reported at 166 per 100,000
population [81]. In a case ﬁnding study in Hawaii, Native
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ematosus prevalence compared to Caucasians (age-adjusted rates
for females were 53 per 100,000 compared to 71 per 100,000
people respectively) [82]. Prior to these publications, estimates of
prevalence of systemic lupus erythematosus in Crow, Arapahoe
and Sioux tribes were reported at being more than 10/100,000 but
without further speciﬁcation [83] (Table 3).
In Canadian First Nations populations, the prevalence of sys-
temic lupus erythematosus in British Columbia’s Nuu-Chah-Nulth
population was estimated at 0.3% [61], with rates in the Manitoba
First Nations population estimated at 42 per 100,000 [84], com-
pared to 27 cases per 10,000 females and 3.2 cases per 10,000
males in Alberta First Nations [85]. These prevalence rates exceed
those reported in non-First Nations populations, by twofold in
Manitoba [84] and by twofold in females 445 years of age in
Alberta [85]. No cases were found in the Inuit population [38].
Several studies from Australia highlight systemic lupus erythema-
tosus prevalence in Aborigine populations to be between 13 per
100,000 and up to 93 per 100,000 population [86–90], with
indigenous prevalence being twofold [90] to fourfold higher than
the non-indigenous population [89].
Incidence rates of systemic lupus erythematosus also appear in
the literature. In Alaska Natives age-adjusted incidence rates were
estimated at up to 7 per 100,000 person-years [49,80], up to 30 per
100,000 person-years in American Indians [49,80,81,83], 11 per
100,000 in Australia [88] and up to 7 per 100,000 in Canadian First
Nations [84].
Other systemic autoimmune rheumatic diseases
A single article studied prevalence of Kawasaki Disease and
Takayasu Arteritis in the Inupiat population (Alaska Native) with
an estimation of 44 cases per 100,000 [47]. Canadian First Nations
from the province of Alberta had an estimated autoimmune
inﬂammatory myopathy prevalence of 25 per 100,000 First
Nations [95% credible interval (CrI): 13.4–49.0] compared to 34
per 100,000 non-First Nations (95% CrI: 28.9–39.6), not signiﬁ-
cantly different [91]; polymyositis was not found in the Alaska
Native population [47]. Scleroderma prevalence has been
described in the Inupiat Alaska Native population at 22 cases per
100,000 [47]; in American Indians no cases in the non-Oklahoma
Choctaw population were found, but estimates of 9.5 cases per
100,000 in the non-Choctaw and 66 cases per 100,000 in the
Oklahoma Choctaw populations were reported [92]. Finally, the
Canadian First Nations population in Alberta was estimated to
have a scleroderma prevalence of 47 cases per 100,000 people
(95% CrI: 33–65), compared to 33 cases per 100,000 in the non-
First Nations population (95% CrI: 29–38) [85] (Table 3).
Juvenile idiopathic arthritis
Three studies of three populations of Alaskan Native children
(Inupiat, Tlingt/Haida/Tsimshian, and Yupik Eskimo) spanning
1970–1984 were identiﬁed in our search. The prevalence rate of
active juvenile idiopathic arthritis was estimated at 83 cases per
100,000 population, and increased to 138 cases per 100,000
population if inactive cases were included in the estimate [48].
Incidence rate estimates ranged between 28 and 42.5 per 100,000
per year [43,47,48]. Using Indian Health Service data, the preva-
lence of juvenile idiopathic arthritis in persons o19 years of age
was estimated at 53 cases per 100,000 population in the Albu-
querque, New Mexico and 115 cases per 100,000 population in the
Billings, Montana districts [93]. Two Canadian studies from similar
time periods reported the prevalence of juvenile idiopathic arthri-
tis in Canadian First Nations children from British Columbia and
Manitoba, and Canadian Inuit children. In First Nations children,the prevalence was estimated at 36 cases per 100,000 population,
compared to that of Caucasians which was 20 cases per 100,000
population [94]. The age-adjusted prevalence rate in Canadian
Inuit children was signiﬁcantly higher at 123 cases per 100,000
population, with an age-adjusted incidence of 23.6 cases per
100,000 population [38]. The remaining three studies of Canadian
indigenous populations reported incidence rates of juvenile idio-
pathic arthritis ranging from 7.2 up to 18.1 cases per 100,000
population [95–97], rates that were two to three times that of the
Caucasian or non-First Nation comparison populations. There were
no studies of juvenile idiopathic arthritis in Australian or New
Zealand indigenous populations.
Juvenile spondyloarthropathies
In an Inuit population studied in the years 1972–1982, the age-
adjusted prevalence of all spondyloarthropathies was 367 cases
per 100,000 population, and the incidence was estimated at 69
cases per 100,000 population per year [38]. An article from the
same time period found the prevalence of juvenile spondyloarthr-
opathy to be 29 cases per 100,000 population in Canadian First
Nations from British Columbia and Manitoba, compared to
3.7 cases per 100,000 population in Caucasians [94]. Using Indian
Health Service data, prevalence rates in the American Indian
populations of Albuquerque and Billings districts were 17 and 42
cases per 100,000 population respectively [93].
Juvenile systemic lupus erythematosus
The epidemiology of juvenile systemic lupus erythematosus
was reported in each of the four countries. An older study reported
prevalence in Canadian British Columbia and Manitoba First
Nations at 4.1 cases per 100,000 population [94]. In two more
recent studies, the prevalence in British Columbia First Nations
people was estimated at 8.8 cases per 100,000 population, sig-
niﬁcantly higher than a rate of 3.3 cases per 100,000 population in
the non-First Nations group [98], but with inverse estimates in
Alberta at 4.0 cases per 100,000 in First Nations children compared
to 8.7 cases per 100,000 in the non-First Nations children [99].
Among US Medicaid beneﬁciaries, Native American children had a
juvenile systemic lupus erythematosus prevalence of 13.4 cases
(95% CI: 10.4–17.2) per 100,000 population compared to 4.9 cases
(95% CI: 4.5–5.3) per 100,000 Caucasian children, with incidence
rates being similar (Native American 1.6 and Caucasian 1.3 cases
per 100,000 population per year) [100]. Among Indian Health
Services users, Albuquerque and Billings rates of juvenile systemic
lupus erythematosus were similar (11 and 14 cases per 100,000
population respectively) [93]. The incidence of juvenile systemic
lupus erythematosus in New Zealand Maori was reported at
0.6 cases per 100,000 population per year (95% CI: 0.3–1.2) which
was not statistically different when compared to children of
European descent although the rate ratio between the populations
was 2 [101]. In an Australian indigenous population derived from
the Australian Pediatric Surveillance Unit, the incidence of juvenile
systemic lupus erythematosus in Aboriginal and Torres Strait
Islanders was reported at 1.3 cases per 100,000 population per
annum (95% CI: 0.5–2.8) compared to the overall pediatric pop-
ulation rate of 0.3 cases per 100,000 population per year (95% CI:
0.2–0.5) [102].
Juvenile systemic autoimmune rheumatic diseases
The prevalence of juvenile polymyositis and dermatomyositis
and scleroderma in Alberta First Nations were each reported at
2.0 cases per 100,000 population compared to non-First Nations
populations estimates of 6.5 and 2.9 cases per 100,000 population
Table 3
Prevalence of systemic lupus erythematosus and other systemic autoimmune rheumatic diseases in the indigenous populations of Canada, the United States of America, New Zealand, and Australia
Condition Study
Years of
study Source of data for case determination Country Population Prevalence estimate, per 100,000 population
Systemic lupus erythematosus Boyer et al. [47] 1970–1982 Computerized patient care database USA Inupiat 44
Boyer et al. [79] 1970–1984 Computerized patient care database USA Alaska Native (Tlingt, Haida, and
Tsimshian)
112 (age-adjusted)
Ferucci et al. [80] 2007–2009 Computerized patient care database USA Alaska Native Primarya: 149 (95% CI: 124–177);
alternative: 159
(95% CI: 133–189) (age-adjusted)
Feldman et al. [81] 2000–2004 Medicaid Analytic eXtract USA American Indian 166 (95% CI: 152–181)
Ferucci et al. [80] 2007–2009 Computerized patient care database USA Oklahoma Primarya: 138 (95% CI: 93–200);
alternative: 147
(95% CI: 100–210) (age-adjusted)
Ferucci et al. [80] 2007–2009 Computerized patient care database USA Phoenix Primarya: 248 (95% CI: 204–297);
alternative: 263
(95% CI: 219–315) (age-adjusted)
Maskarinec et al. [82] 1989 Case ﬁnding (medical centers, and
Hawaii Lupus Foundation mailing list)
USA Native Hawaiian Females ¼ 53, males ¼ 7 (age-adjusted)
Atkins et al. [61] 1971–1986 Medical records Canada First Nations (Nuu-Chah-Nulth) 348
Peschken and
Esdaile [84]
1980–1996 Case ﬁnding by surveying healthcare
providers
Canada First Nations (Manitoba) 42 (95% CI: 30–54) (age-adjusted
Barnabe et al. [85] 1994–2007 Administrative databases Canada First Nations (Alberta) Females ¼ 322 (95% CrI: 265–392),
males ¼ 32
(95% CrI: 18–54)
Oen et al. [38] 1972–1982 Clinical visit and investigations Canada Inuit 0
Bloor et al. [89] 1976 Medical records Australia Aborigine (Western) 22
Anstey et al. [88] 1984 to 1991 Medical records Australia Aborigine (Northern Territory) 52
Segasothy et al. [86] 1990–1999 Medical records Australia Aborigine (Central Australia) 74
Grennan et al. [87] 1993–1994 Physician survey Australia Aborigine (Northern Queensland) 89
Grennan et al. [87] 1993–1994 Physician survey Australia Aborigine (urban Sydney) 13
Bossingham et al. [90] 1996–1999 Rheumatology clinic records Australia Australian indigenous 93
Autoimmune Inﬂammatory
Myopathy
Boyer et al. [47] 1970–1982 Computerized patient care database USA Inupiat 0
Barnabe et al. [91] 1994–2007 Administrative databases Canada First Nations (Alberta) 25
Kawasaki Disease and Takayasu
Arteritis
Boyer et al. [47] 1970–1982 Computerized patient care database USA Inupiat 44
Scleroderma Boyer et al. [47] 1970–1982 Computerized patient care database USA Inupiat 22
Arnett et al. [92] 1990–1994 Computerized patient care database USA Non-Choctaw 9.5
Arnett et al. [92] 1990–1994 Computerized patient care database USA Non-Oklahoma Choctaw 0
Arnett et al. [92] 1990–1994 Computerized patient care database USA Oklahoma Choctaw 66
Barnabe et al. [85] 1994–2007 Administrative databases Canada First Nations (Alberta) 47
CI, conﬁdence interval; CrI, credible interval (from Bayesian analysis).
a Primary deﬁnition required 4 American College of Rheumatology criteria documented; the Alternative deﬁnition required 3 American College of Rheumatology and a physician diagnosis.
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alence was 4 and 13 cases per 100,000 American Indian population
of Oklahoma and Billings respectively [93].Discussion
This work is the ﬁrst piece of understanding rheumatic disease
burden in indigenous communities of Canada, the United States of
America, Australia, and New Zealand. We have assembled all
identiﬁable and available data to create a comprehensive summary
of rheumatic disease prevalence and incidence in the indigenous
populations from four countries that live in similar socio-political
contexts and experience disparities in social determinants of
health as a legacy of colonial practices. Prevalence and incidence
statistics provide information for understanding health service
need in the community, allowing for health service delivery
planning. These statistics are also tools for monitoring the health
status of communities over time, in particular when interventions
to address underlying causes of disease are instituted.
The key ﬁnding from our systematic review is that of a high
prevalence of many rheumatic diseases in indigenous populations
of all four countries, notably osteoarthritis, rheumatoid arthritis,
and systemic lupus erythematosus. Data from North America
supports the increased prevalence of juvenile idiopathic arthritis
in the indigenous populations of that continent, and of gout in
Maori compared to general population New Zealanders. In instan-
ces where comparisons between indigenous and non-indigenous
populations were made, it is noticeable that the burden of these
conditions is typically two to fourfold higher in the former group.
The review also highlights knowledge gaps in rheumatic dis-
ease distribution. Many studies were performed decades ago in
speciﬁc communities, using case ﬁnding strategies based on
clinical diagnosis. These intensive studies are certainly of value
locally but are not feasible to perform in a nationally representa-
tive way, leaving residual information gaps on populations not
studied. In particular, our review highlights notable gaps in disease
prevalence in particular indigenous groups, such as the Inuit and
Métis in Canada. There is great heterogeneity in the indigenous
populations within countries, highlighting a clear need to expand
surveillance for rheumatic diseases using careful and thoughtful
methods of identifying population groups, informed by the pop-
ulations themselves, and with a clear objective to using the
information to improve the current health status.
The case deﬁnitions for the arthritis conditions of interest
applied by the primary investigators of the studies we identiﬁed
proved problematic in our review. Many clinical case ﬁnding
studies did not apply standardized diagnostic criteria. More con-
temporary studies have employed the use of health system records
and administrative databases to search for cases using diagnostic
algorithms; this may lead to underestimation of disease preva-
lence, as only patients who choose to contact the healthcare
system will be captured. The rates presented in the identiﬁed
articles were heterogeneous in their ways of deﬁning the total
population denominator, such as using entire census population
statistics, or limiting by age and/or gender. Most studies only
presented crude prevalence rates, with age standardization to the
general population being the most common method of adjustment
if performed. These factors limited our ability to perform quanti-
tative syntheses. We also noted relatively little information is
available about incidence rates, which is again a critical piece of
information for health service delivery planning, especially in our
desire to achieve early diagnosis and treatment initiation.
In comparison to the prior reviews performed [1,2], we feel that
we have expanded both the scope of diseases presented (arthritis
and rheumatism to capture a broad view of population-levelrheumatic disease burden), updated the search results as both
studies were performed over a decade ago, and contributed
relevant information by including the studies from Australia and
New Zealand. We recognize that indigenous populations in other
countries likely also face rheumatic disease inequities that require
further understanding and action. For example, the work of
GLADERPO (Grupo Latino Americano de studio De Enfermedades
Reumaticas en Pueblos Originarios) carries out epidemiological,
genetic and anthropological studies related to rheumatic diseases
in indigenous peoples of Latin America [103]. The next phases of
the work include identifying clinical outcomes and existing health
service use in the indigenous populations of the four countries of
interest, to complete our view of the existing state of rheumatic
disease care.Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.semarthrit.2016.
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